Clinical trial
Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
NCT00372125 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
- Lead sponsor
- Karolinska University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- March 31, 2010
- Enrollment
- 46 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.